Legal & General Group Plc Acquires New Holdings in The Cooper Companies, Inc. $COO

Legal & General Group Plc acquired a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, Holdings Channel reports. The institutional investor acquired 843,973 shares of the medical device company’s stock, valued at approximately $60,521,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of COO. BlackRock Inc. bought a new stake in shares of Cooper Companies during the 2nd quarter worth about $1,077,762,000. Generation Investment Management LLP bought a new position in shares of Cooper Companies in the second quarter valued at approximately $356,304,000. Wellington Management Group LLP boosted its holdings in shares of Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after acquiring an additional 4,756,178 shares in the last quarter. Diamond Hill Capital Management Inc. increased its stake in shares of Cooper Companies by 479.6% during the fourth quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after acquiring an additional 2,720,594 shares during the period. Finally, Price T Rowe Associates Inc. MD raised its holdings in Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after purchasing an additional 2,231,568 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Robert W. Baird cut their target price on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. BNP Paribas Exane lowered their price target on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Needham & Company LLC cut their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. Finally, Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Hold” and an average target price of $81.64.

Cooper Companies Stock Up 0.3%

COO stock opened at $71.17 on Friday. The firm has a market cap of $13.88 billion, a PE ratio of 60.31, a P/E/G ratio of 1.85 and a beta of 0.83. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The firm has a 50 day simple moving average of $72.56 and a 200 day simple moving average of $70.88.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the previous year, the business posted $0.96 earnings per share. The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.